2.jpg

Diseased cartilage is restored with Novocart 3D.

Dr. Hutchison accepted into clinical study

Dr. Jason Hutchison of West Tennessee Bone & Joint Clinic was accepted into the Novocart 3D Clinical Study that is currently enrolling patients in the United States.

He is the only surgeon in Tennessee who has been accepted into this clinical research study, which is designed to evaluate a new surgical technology’s ability to restore diseased cartilage.

The product has been available commercially in Europe for several years with favorable results. The U.S. Food and Drug Administration is requiring that a controlled study be done in the United States before the product can be commercially used. Dr. Hutchison and West Tennessee Bone & Joint Clinic have been selected as a center to study this product. 

The study is a randomized, partially blinded, multi-center study that compares this new technology to the current microfracture surgery, which attempts to deal with the issue of diseased cartilage.

“I believe Novocart 3D has the potential to change the way we currently address articular cartilage lesions,” said Dr. Hutchison.
Dr. Hutchison describes the procedure as occurring in two stages.

The first stage is a small surgery where the arthroscope is inserted into the knee, and a small biopsy of the patient’s articular cartilage is removed. The biopsy is sent to the clinical laboratory where the patient’s own cartilage cells are purified and reproduced many times to concentrate them.

They are then implanted on a special membrane, which secures them and distributes them uniformly. The membrane is then shipped back to the clinical site for surgical re-implantation.

The second stage of the surgery requires a larger incision to re-implant the patient’s cartilage cells on the membrane into the cartilage defect within the knee.
Extensive rehabilitation and follow-up are necessary after the second surgery to evaluate the patient’s recovery.

The study is enrolling only subjects who have a particular type of cartilage defect in the knee. 

“I am very excited about the opportunity to offer a clinical study that has this much potential to my patients here in West Tennessee,” said Dr. Hutchison.

The study will continue to enroll patients for the next two years. For more information, contact West Tennessee Bone & Joint, or schedule an appointment with Dr. Hutchison to see if you may be a candidate.